Ключевые слова:
inkrustatsiyalanuvchi sistit, surunkali yallig‘lanish, qaytalanish, jarrohlik davolash, differensial yondashuv.Библиографические ссылки
1. Fernández-Roblas R, Prieto S, Fernández-Roblas M et al. Activity of nine antimicrobial agents against Corynebacte- rium group D2 strains isolated from clinical specimens and skin. Antimicrob Agents Chemother.1987;31:821-2. 10.1128/ AAC.31.5.821
2. García-Rodriguez JA, García Sánchez JE, Muñoz Bellido JL et al. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2. Antimicrob Agents Chemoth-
er.1991;35:2140-3. 10.1128/AAC.35.10.2140
3. Masson JC, Charriere D, Masson J, Variani JP. Coryne- bacteria D2 and encrusted cystitis with alkaline urine. Prog Urol.19922(6):1012-7.
4. Meria P, Desgrippes A, Fournier R, Arfi C et al. The con- servative management of corynebacterium group D2 encrust- ed pyelitis. Brit J Urol Int.1999;84:270-5. 10.1046/j.1464- 410x.1999.00156.x
5. Parsons CL, Stauffer C, Mulholland SG, Griffith DP. Ef- fect of ammonium on bacterial adherence to bladder transi- tional epithelium. J Urol.1984;132:365-6. 10.1016/S0022- 5347(17)49628-5
6. Sabiote L, Emiliani E, Kanashiro AK et al. Oral acidification with L-methionine as a noninvasive treatment for encrust- ed uropathy. J Endourol Case Rep.2020;6:143-6. 10.1089/ cren.2019.0164
7. Sánchez Hernández J, Mora Peris B, Yagüe Guirao G et al. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. Int J Antimicrob Agents.2003;22:492-6. 10.1016/ S0924-8579(03)00121-3
8. Sánchez-Martín FM, López-Martínez JM, Kanashiro-Az- abache A et al. Corynebacterium urealyticum: increased incidence of infection and encrusted uropathy. Actas Urol Esp.2016;40:102-7. 10.1016/j.acuroe.2016.01.007
9. Sofras F, Yiannopoulou K, Kostakopoulos A, Dimopoulos
C. Corynebacterium-induced cystitis with mucosal incrustra- tions. J Urol.1988;139(4):810.
10. Soriano F, Huelves L, Naves P et al. In vitro activity of cip- rofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. J Antimicrob Chemother.2009;63:353-6. 10.1093/jac/dkn491
11. Soriano F, Ponte C, Santamaría M et al. Corynebacterium group D2 as a cause of alkalineencrusted cystitis: Report of four cases and characterization of the organisms. J ClinMicro- biol.1985;21:788-92
12. Soriano F, Ponte C, Santamaría M, Fernández-Roblas R. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid. J Antimi- crob Chemother.1987;20:349-55. 10.1093/jac/20.3.349
13. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibili- ties of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother.1995;39:208-14. 10.1128/AAC.39.1.208
14. Van de Perre E, Reichman G, De Geyter D et al. Encrust- ed Uropathy: A Comprehensive Overview-To the Bottom of the Crust. Front Med (Lausanne).2021;7:609024. doi: 10.3389/ fmed.2020.609024. PMID: 33553205; PMCID: MC7858656.
